A novel chemically modified curcumin reduces inflammation‐mediated connective tissue breakdown in a rat model of diabetes: periodontal and systemic effects

Abstract

This study supports our hypothesis that CMC 2.24 is a potential therapeutic pleiotropic MMP inhibitor, with both intracellular and extracellular effects, which reduces local and systemic inflammation and prevents hyperglycemia- and bacteria-induced connective tissue destruction.